about
Beta-blockers for heart failurebeta Blockade after myocardial infarction: systematic review and meta regression analysisBarriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.Heart failure: Part IIInterpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?Recent advances in the management of chronic heart failure.Metoprolol: a review of its use in chronic heart failure.Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients?New and emerging pharmacologic strategies in the management of chronic heart failure.The use of a new continuous wireless cardiorespiratory telemonitoring system by elderly patients at home.New Zealand and United Kingdom experiences with the RAND modified Delphi approach to producing angina and heart failure criteria for quality assessment in general practice.Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study.Chronic vagus nerve stimulation improves left ventricular function in a canine model of chronic mitral regurgitation.Improving patient outcomes in heart failure: evidence and barriersImportance of beta blockade in the treatment of advanced heart failurePeri-operative beta-blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery.Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failureCardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis.Carvedilol in the treatment of elderly patients with chronic heart failure.Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.Beta-blockers for heart failure.Pharmacological management of chronic heart failure in adults: a review of the literature.Relationship between chronotropic incompetence and β-blockers based on changes in chronotropic response during cardiopulmonary exercise testing.Treatment of myocardial infarction should be audited before heart failure clinics are set up.Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)
P2860
Q24186864-A6C01A54-7663-4382-A993-2ECC700AF573Q24621730-0FE3ACA0-0726-4AA4-A905-5821697B1DE0Q30575444-7875CDEA-8526-4BA3-A0D2-336412A6F96FQ30619311-CE351348-A72A-443C-A077-C6286354C39EQ33708950-0E7BC6F0-40F5-4A34-9900-0B8CEA8FF800Q33805130-91F47243-C1BE-43F9-8E37-4BFC9B634F4CQ34031741-F621E7D2-2C84-40A0-B58F-404B81699EB5Q34059392-22BEFA57-8E40-4AB7-A678-A9D5111EFAB1Q34070051-58A245D9-7B5B-4575-9289-85B88D1B68DAQ34075359-880B9E9F-9CFA-4E19-9D50-E8903644FB32Q34092927-D738AB01-A44E-4859-BD02-3C660EDC0C45Q34095882-C4ED4C95-9F52-43C3-901C-D82F534C3DCCQ34451993-53C707D3-B0B9-45C7-9640-16DE3D3890C5Q34491997-C8AE32D4-503B-4C31-B5B4-133ACD86B5A7Q35578969-D1B0C73E-8F4F-4EC7-9264-B3800382D014Q35581838-B80E2EBB-7B02-43A5-A9DF-2B371DCCB720Q35612101-D87F9282-B505-4BFD-B599-6D283307A5CCQ35771399-6775CAA8-5662-4033-B402-AC69101C4F3DQ36409329-E2A89FE5-1231-48F9-BC5D-579024754FB3Q36892905-F2DF472A-A0B8-44AB-A454-84A356A3D2DFQ37494358-BF3006E5-976D-478B-8670-A6E04584B863Q38269854-8BAA065C-40B2-4870-849E-AFF27681C207Q38928686-DCD1B358-BD33-4389-B08B-25A66FFD5A7EQ40964503-5FA0121C-E776-4704-9AE3-6FCDDB4BB58DQ42763306-3B7BE1D2-FFE0-444B-B976-3FA4316F20B7Q43711820-A99A57F9-D925-46F0-B397-72E820B96CFDQ44008862-09E24EE6-E2EF-4EEE-9F74-9ED7E427DA3BQ50668477-30539782-3C8B-4579-BD8D-47C8A863BDF3Q57403354-CF36424A-0CAE-4905-865C-4762FA05878B
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The evidence for beta blockers in heart failure
@en
The evidence for beta blockers in heart failure
@nl
type
label
The evidence for beta blockers in heart failure
@en
The evidence for beta blockers in heart failure
@nl
prefLabel
The evidence for beta blockers in heart failure
@en
The evidence for beta blockers in heart failure
@nl
P2093
P2860
P356
P1433
P1476
The evidence for beta blockers in heart failure
@en
P2093
J G Cleland
N Freemantle
P2860
P304
P356
10.1136/BMJ.318.7187.824
P407
P577
1999-03-01T00:00:00Z